{
    "eid": "2-s2.0-85089101240",
    "title": "Deficit schizophrenia and its features are associated with PON1 Q192R genotypes and lowered paraoxonase 1 (PON1) enzymatic activity: Effects on bacterial translocation",
    "cover-date": "2021-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Psychiatry and Mental Health",
            "@code": "2738",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "antioxidants",
        "bacteria",
        "Deficit schizophrenia",
        "inflammation",
        "oxidative and nitrosative stress"
    ],
    "authors": [
        "Andressa K. Matsumoto",
        "Michael Maes",
        "Thitiporn Supasitthumrong",
        "Annabel Maes",
        "Ana P. Michelin",
        "Laura De Oliveira Seme\u00e3o",
        "Jo\u00e3o V. De Lima Pedr\u00e3o",
        "Estefania G. Moreira",
        "Buranee Kanchanatawan",
        "Decio S. Barbosa"
    ],
    "citedby-count": 9,
    "ref-count": 69,
    "ref-list": [
        "SZDB: A database for schizophrenia genetic research",
        "Deficit schizophrenia is a discrete diagnostic category defined by neuro-immune and neurocognitive features: Results of supervised machine learning",
        "Towards a new classification of stable phase schizophrenia into major and simple neuro-cognitive psychosis: Results of unsupervised machine learning analysis",
        "Schizophrenia: A conceptual history",
        "Immune-inflammatory markers in schizophrenia: Comparison to normal controls and effects of clozapine",
        "Acute phase proteins in schizophrenia, mania and major depression: Modulation by psychotropic drugs",
        "Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug na\u00efve first episode psychosis",
        "Deficit schizophrenia is characterized by defects in IgM-mediated responses to tryptophan catabolites (TRYCATs): A paradigm shift towards defects in natural self-regulatory immune responses coupled with mucosa-derived TRYCAT pathway activation",
        "Eotaxin, an endogenous cognitive deteriorating chemokine (ECDC), is a major contributor to cognitive decline in normal people and to executive, memory, and sustained attention deficits, formal thought disorders, and psychopathology in schizophrenia patients",
        "A new schizophrenia model: Immune activation is associated with the induction of different neurotoxic products which together determine memory impairments and schizophrenia symptom dimensions",
        "Upregulation of the intestinal paracellular pathway with breakdown of tight and adherens junctions in deficit schizophrenia",
        "Breakdown of the paracellular tight and adherens junctions in the gut and blood brain barrier and damage to the vascular barrier in patients with deficit schizophrenia",
        "The role of aberrations in the immune-inflammatory response system (IRS) and the compensatory immune-regulatory reflex system (CIRS) in different phenotypes of schizophrenia: The IRS-CIRS theory of schizophrenia",
        "In schizophrenia, increased plasma IgM/IgA responses to gut commensal bacteria are associated with negative symptoms, neurocognitive impairments, and the deficit phenotype",
        "In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde",
        "Schizophrenia: Linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression",
        "Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia",
        "Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries",
        "A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis",
        "Why should psychiatrists and neuroscientists worry about paraoxonase 1?",
        "Lowered PON1 activities are strongly associated with depression and bipolar disorder, recurrence of (hypo)mania and depression, increased disability and lowered quality of life",
        "The effect of HDL-bound and free PON1 on copper-induced LDL oxidation",
        "Phenotypic variants of paraoxonase Q192R in bipolar disorder, depression and schizophrenia",
        "Determination of paraoxonase 1 status without the use of toxic organophosphate substrates",
        "Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease",
        "The evolutionary origins of detoxifying enzymes: The mammalian serum paraoxonases (PONs) relate to bacterial homoserine lactonases",
        "The schedule for the deficit syndrome: An instrument for research in schizophrenia",
        "The Scale for the Assessment of Negative Symptoms (SANS): Conceptual and theoretical foundations",
        "The Positive and Negative Syndrome scale (PANSS) for schizophrenia",
        "The Brief Psychiatric Rating scale",
        "A rating scale for depression",
        "Detection of the specific IgM and IgA circulating in sera of multiple sclerosis patients: Interest and perspectives",
        "The gut-brain barrier in major depression: Intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression",
        "Controlling the false discovery rate-A practical and powerful approach to multiple testing",
        "Paraoxonase-1 55/192 genotypes in schizophrenic patients and their relatives in Turkish population",
        "Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification",
        "Activated neuro-oxidative and neuro-nitrosative pathways at the end of term are associated with inflammation and physio-somatic and depression symptoms, while predicting outcome characteristics in mother and baby",
        "Relationship of human paraoxonase-1 serum activity and genotype with atherosclerosis in individuals from the Deep South",
        "A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression",
        "Activity of serum paraoxonase and its polymorphism in healthy Chinese of Shanghi",
        "Profile of the paraoxonase 1 (PON1) gene 192Q/R polymorphism and clinical associations among older Singaporean Chinese with Alzheimer's and mixed dementia",
        "Increased mortality in schizophrenia due to cardiovascular disease-A non-systematic review of epidemiology, possible causes, and interventions",
        "Effects of paraoxonase 1 gene polymorphisms on heart diseases: Systematic review and meta-analysis of 64 case-control studies",
        "Paraoxonase 1 genetic polymorphisms and susceptibility to breast cancer: A meta-analysis",
        "Paraoxonase 1 (PON1) Q192R gene polymorphism and cancer risk: A meta-analysis based on 30 publications",
        "Association of schizophrenia with the risk of breast cancer incidence: A meta-analysis",
        "Type-2 diabetes mellitus in schizophrenia: Increased prevalence and major risk factor of excess mortality in a naturalistic 7-year follow-up",
        "Paraoxonase 1 phenotype distribution and activity differs in subjects with newly diagnosed Type 2 diabetes (the CODAM Study)",
        "Amendment of amino acid in Q192R genetic polymorphism of paraoxonase 1 is a conventional risk factor for type 2 diabetes mellitus in the Saudi population",
        "European versus Asian differences for the associations between paraoxonase-1 genetic polymorphisms and susceptibility to type 2 diabetes mellitus",
        "Oxidative stress in drug naive first episode psychosis and antioxidant effects of risperidone",
        "Genotype-phenotype analysis of paraoxonase 1 in schizophrenic patients treated with atypical antipsychotics",
        "Paraoxonase 1 (PON1) polymorphisms, haplotypes and activity in predicting cad risk in North-West Indian Punjabis",
        "Paranoid schizophrenia and methamphetamine-induced paranoia are both characterized by a similar LINE-1 partial methylation profile, which is more pronounced in paranoid schizophrenia",
        "Functionality of HDL: Antioxidation and detoxifying effects",
        "Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex",
        "Inhibition of Pseudomonas aeruginosa biofilm formation and motilities by human serum paraoxonase (hPON1)",
        "Multiplicity of quorum quenching enzymes: A potential mechanism to limit quorum sensing bacterial population",
        "Divergence and convergence in enzyme evolution: Parallel evolution of paraoxonases from quorum-quenching lactonases",
        "Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities",
        "Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues",
        "Pseudomonas aeruginosa virulence and therapy: Evolving translational strategies",
        "The endophenotype project and the validation theory: Integration of neurobiology and psychiatry",
        "Schizophrenia phenomenology comprises a bifactorial general severity and a single-group factor, which are differently associated with neurotoxic immune and immune-regulatory pathways",
        "Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia",
        "The endophenotype concept in psychiatry: Etymology and strategic intentions",
        "The forms of schizophrenia and their biological correlates"
    ],
    "affiliation": [
        {
            "affiliation-city": "Beerse",
            "@id": "60068574",
            "affilname": "Janssen Pharmaceutica, Headquarters",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60068574",
            "affiliation-country": "Belgium"
        },
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Londrina",
            "@id": "60027866",
            "affilname": "Universidade Estadual de Londrina",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027866",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Asahi Glass Foundation",
        "Chulalongkorn University",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}